Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

NCT00766545 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1095

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebral Infarction

Interventions

DRUG: cilostazol
DRUG: placebo of cilostazol

Sponsor

Otsuka Pharmaceutical Co., Ltd.